Apotheka acquires two pharmacy outlets from Panpharmacy
In a strategic move that signifies the ongoing consolidation and growth within the Latvian pharmaceutical retail sector, Panpharmacy, the parent company of the leading online pharmacy InternetAptieka.lv, has successfully completed the sale of two of its brick-and-mortar pharmacies to Apotheka. These pharmacies, both situated in the capital city of Riga, will continue to serve customers under the Apotheka brand, marking a seamless transition in ownership and operations.
InternetAptieka.lv is recognized as the premier online pharmacy platform in Latvia, offering a wide range of pharmaceutical products and health-related services to its customers. This divestiture allows Panpharmacy to potentially refocus resources and further strengthen its leading position in the digital pharmacy space.
Apotheka is a prominent name in the Latvian pharmaceutical retail landscape. The company currently operates more than 120 pharmacies across Latvia, with a significant presence in Riga as well as major cities such as Liepaja, Ventspils, Jelgava, Daugavpils and Rezekne. Apotheka is part of Magnum Group, a leading group in pharmaceutical wholesaling and retailing in the Baltic States.
Oaklins’ team in Latvia acted as the exclusive M&A advisor to Panpharmacy and its shareholders.
Contáctese con el equipo de la transacción
Transacciones relacionadas
MEDIK Hospital Design Group has been acquired by STERIS
The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.
Ver másbioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG
Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.
Ver másBanook, backed by Motion Equity, has acquired Fluidda
Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.
Ver más